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Abstract 
Background: Human amniotic membranes (HAMs) are assumed to have a number of unique 
characteristics including durability, hypoallergenic and anti-inflammatory properties.  
Materials and Methods: Multilayer HAMs from caesarian sections were applied to repair defined 
bladder defects in male Sprague-Dawley rats. The animals were sacrificed at 7, 21 and 42 days after 
implantation. Bladder volume capacity after grafting was measured. Histological analyses were 
performed to asses a number of parameters including HAM degradation, inflammatory reaction, 
graft rejection and smooth muscle ingrowth. 
Results: One rat died from sepsis in the treated group. No severe complications or signs of leakage 
were observed. Bladder capacity did not change over time. The initially increased inflammation in 
the HAM group diminished significantly over time (p<0.05). No signs of HAM degradation were 
observed and smooth muscle staining increased over time. 
Conclusions: HAMs appear to be durable and hypoallergenic grafts. The assumed suitability for the 
reconstruction of urinary tract justifies further research on detailed immunological process in 
larger grafts. 
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Introduction 
Defects of urinary tract can be caused by a 
multitude of complications and events, such as 
catheterization-related urethral and ureteral 
strictures, surgery, stone passage or infections or 
fistulas. Preservation of continence and social 
autonomy after oncological surgery or radiation are 
gaining importance. One of the major reconstructive 
problems relates to lack of healthy native tissue for 
repair in patients, who have received multiple 
radiation treatments or undergone multiple surgeries. 
Autolog, xenolog and synthetic materials have been 
tested for the reconstruction of urinary tract defects, 
but these experiments have not yielded any 
sustainable results for a number of reasons, including 
degradation, rejection or inflammation of the graft or 
scarring due to reduced perfusion. 
New scaffolds and biomaterials are needed to 
achieve a fast regeneration without adverse effects. At 
present, four different approaches are applied: 
synthetic polymers (polyglycolic- (PGA), polylactic 
acid (PLA)), biologically derived materials (bladder 
acellular matrix), cell-based tissue engineering and 
composite materials [1]. Synthetic materials are 
available but cause additional complications and 
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serious concerns have recently been raised about the 
use of alloplastic materials in the pelvic floor [2]. The 
composite scaffolds were fabricated by binding 
collagen with PGA. Advances in tissue engineering 
technology have enabled seeding of scaffolds with 
autologous bladder epithelial and smooth muscle 
cells. Several experimental and clinical pilot studies 
have shown the potential of neo-bladder formation 
with a structure that is similar to that of native 
bladder tissue. For instance, improved bladder 
capacity was seen in seven patients with 
myelomeningocele following cystoplasty with 
engineered bladder tissue [3]. A prospective 
multicenter phase II trial from USA used a similar 
cell-seeded bio-degradable collagen scaffold for 
bladder augmentation in children and adolescents 
with spina bifida (n=11, follow up 36mos), but no 
improved bladder capacity or bladder compliance 
were observed, while several serious adverse events 
occurred [4]. Another strategy consists in applying 
naturally derived acellular matrices, such as small 
intestinal submucosa (SIS) or bladder acellular matrix 
(BAM), in an attempt to induce a native cell seeding of 
urothelial and smooth muscle cells from the 
neighboring native bladder tissue or ureters. Several 
experimental trials with rat, dog, sheep and porcine 
models have reported promising short-term results 
over the last two decades. However, the main 
problems are fibrosis and graft shrinkage of the large 
scaffolds, along with fast degradation, the need for 
immune therapy and the insufficient cell seeding due 
to a lack of tissue growth factors [5-9]. An Italian 
group augmented the bladders of five patients with 
exstrophic bladders using a SIS scaffold and included 
a long-term follow-up period of 3 years. After 6 
months there was no histological evidence of SIS with 
feasible regeneration. However, poor results were 
obtained in terms of muscle regeneration, bladder 
capacity and continence [10]. Correct muscle 
alignment, proper innervation and vascularization are 
crucial for the development of larger contractile 
tissues that allow physiological voiding. Current 
research efforts in many centers are aimed at 
developing ‘smart’, biologically active biomaterials 
that improve tissue regeneration [11]. 
We hypothesized that the regeneration of 
important bladder wall components, such as 
urothelium, vascularization and smooth muscle, can 
be improved by application of hypoallergenic HAMs 
containing multiple growth factors. Outcomes of 
reconstruction of an experimental bladder defect 
using this scaffold were compared with outcomes in a 
group that was repaired with suture only. Following 
the evolving IDEAL-Device (Idea, Development, 
Evaluation, Assessment and Longterm) framework 
for evaluation and regulation of surgical innovations, 
we established a preclinical xenograft model to 
provide evidence that HAMs are instrumental in 
repairing bladder defects. These experiments can be 
categorized as a stage 0 preclinical study for the 
evaluation of a new medical product according to 
IDEAL-D [12, 13]. 
Materials and Methods 
Human amniotic membrane (HAM) 
HAMs were obtained immediately after elective 
cesarean sections with normal gestation and informed 
consent of the patients. Ethical permission was 
obtained from the local ethics committee, University 
of Szeged. The study has been conducted according to 
the principles expressed in the Declaration of 
Helsinki. The donors were screened for infections 
including HIV, hepatitis and syphilis. The placenta 
was cleaned of blood clots with sterile 
phosphate-buffered saline (PBS) and the amnion was 
separated from the chorion by blunt dissection under 
the laminar flow. The separated membranes were cut 
into segments of at least 5 x 5 cm2 with the epithelial 
side up. After several rinsing steps the HAMs were 
frozen at -20°C for 24 hours until further use. For 
further processing, the HAMs were defrosted in 
water, sterilized in peracetic acid and alcohol mixture, 
and incubated for 2 hours on the shaker. After rinsing 
the HAMs were prepared in four layers applied on a 
sterile silicon scaffold and dried under laminar flow 
(Fig. 1).  
Experimental animals 
The animal experiment was conducted at the 
Institute for Experimental Surgery of the University of 
Szeged, Hungary, in accordance with the National 
Institutes of Health guidelines (Guide for the Care 
and Use of Laboratory Animals). The experimental 
protocol was approved by the Animal Welfare 
Committee at the University of Szeged (license 
number V./146/2013). The experiments were 
performed according to the EU Directive 2010/63/EU 
on the protection of animals used for experimental 
and other scientific purposes and carried out in strict 
adherence to the NIH guidelines for the use of 
experimental animals. The study was approved by the 
National Scientific Ethical Committee on Animal 
Experimentation (National Competent Authority). 
Twenty-seven male Sprague-Dawley rats, 
weighing from 320 to 380g and 3 months old, were 
housed and cared for at Szeged University’s farm for 
experimental animal studies. All animals had free 
access to food and water and were cared for by an 
educated keeper and routinely inspected by a 
veterinarian.  
Int. J. Med. Sci. 2017, Vol. 14 
 
 
http://www.medsci.org 
312 
 
Figure 1. A. Preparation of amniotic membrane with dissection from the chorion under laminar flow. B. Dried and cryopreserved multilayered amniotic membrane 
graft. 
 
Operation procedure 
The procedures were performed by two 
surgeons (DB and HG) using sterile surgical 
techniques. Sprague-Dawley rats were anesthetized 
with 40 mg/kg of ketamine 10%. The abdomen was 
shaved and prepared with an ethanol-propanol 
solution. Rats were operated in supine position. A 
microscope and microsurgical instruments were used. 
A midline laparotomy was performed. The bladder 
was identified and bladder capacity was determined 
(ml) before grafting in a standardized way. Evaluation 
of bladder pressure was performed via a cystometric 
method adapted from Lundbeck et al. [14]. After the 
dome of the bladder was exposed a 20 gauge needle 
was inserted through a small puncture in the dome of 
the bladder and secured in the place by a clamp. The 
bladder was emptied by a syringe. The needle was 
attached to an infusion system at 20 cm height above 
the bladder. Room temperature saline was infused by 
gravity and the bladder capacity was measured at the 
timepoint of infusion stop. The bladder was emptied, 
the procedure repeated two additional times, and the 
mean value recorded. Subsequently, the defined 0.5 
cm lesion was cut at the bladder dome. In the treated 
amnion group (A, n=18) a multilayer amnion patch 
was trimmed overlapping the defect size (10x10 mm) 
and fixed to the bladder wall with 6-0 monocryl 
(Ethicon, Norderstedt, Germany) single sutures at 
three to four points. Additionaly human fibrin glue 
(Evicel, OMRIX Biopharmaceuticals Ltd, Israel) was 
used to seal the lesion. In the first control group (C1, 
n=6) the defect was closed with a single monocryl 6-0 
running suture and fibrin glue. In the second control 
group (C2, n=3) the amnion graft was sutured to the 
bladder wall without prior lesion. Fluid loss was 
compensated by administering 3 ml of 0.9% saline 
intraperitoneally at the end of surgery. Subsequently, 
the abdominal fascia and skin were closed in layers 
with absorbable Vicryl 5-0 running suture and 
Monocryl 4-0 interrupted suture (Ethicon, 
Norderstedt, Germany).  
The animals were sacrificed at one (A, n=5; C1, 
n=2; C2, n=1), three (A, n=6; C1, n=2; C2, n=1) and six 
(A, n=5; C1, n=2; C2, n=1) weeks after surgery. 
Bladder capacity was determined again. 
Subsequently, urinary bladder and tissue samples 
(urinary bladder, kidneys, spleen) were harvested and 
stored in 10% formalin solution for 2 hours and then 
stored in PBS at 4°C.  
Clinical Assessment 
Grafts and bladder wall were assessed regarding 
color, tissue contraction, inflammation and pliability 
by two surgeons (D.B. and H.G.). Results were 
documented by photograph. 
Histology and Immunohistochemistry 
All specimens were fixed and embedded in 
paraffin wax. Deparaffinized sections (5 μm) were 
used for staining with Hematoxylin and Eosin (H&E) 
to visualise tissue architecture and cell infiltration. 
Immunohistochemical staining was performed using 
an antibody against alpha-smooth muscle actin 
(α-actin; A2547; Sigma-Aldrich, Bornem, Belgium) to 
confirm the presence of smooth muscle fibres. Tissue 
sections were deparaffinized, rehydrated and 
subjected to a heat-induced antigen retrieval (Citrate 
Buffer, pH 6.0), followed by 3% hydrogen peroxide 
and avidin-biotin blocking. Prior to incubation with 
the primary antiserum, sections were incubated with 
PBS blocking solution containing 10% normal horse 
serum, 0.1% bovine serum albumin, 0.05% thimerosal, 
0.01% NaN3 and 1% Triton X-100. Primary and 
secondary antiserum were diluted in blocking 
solution without Triton X-100. Sections were 
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incubated overnight with the primary antibody and 
immunostained with streptavidin-biotin-peroxidase 
method, followed by diaminobenzidine (DAB) 
chromogen solution. Finally, sections were 
counterstained with hematoxylin and mounted in 
xylene-based mountant. Negative controls were 
incubated in blocking solution without primary 
antibodies. Pictures were taken using an Zeiss 
Axiophot microscope (Zeiss, Jena, Germany) equiped 
with an Olympus DP70 digital camera (Olympus, 
Münster, Germany) at 4x magnification. 
Particular attention was paid to the slides 
showing the transition zone between the amnion graft 
and normal bladder wall. Semi-quantitative scores 
from 0 to 3 for inflammation were used. Inflammation 
of the implant region was scored by counting 
lymphocytes in 10 fields of 0.25 mm2 in three 
observer-randomized H&E slides (semi-quantitative 
score: 0 = <5% cells/field; 1 = 5-25%; 2 = 25-50%; 3 = 
>50%; 200x magnification). AM-thickness was 
measured in µm to assess degradation and 
inflammation. Kindneys and spleen specimen were 
analysed for signs of transplant rejection. 
Statistical analysis 
The data were documented into Microsoft Excel 
software and then transferred into a 
GraphPadPrism6.0 (Graphpad Software, Inc.) data 
bank for statistical analysis. Continuous data were 
checked for normality of distribution before choosing 
between parametric and non-parametric tests. The 
results were presented as medians with range or 
means with standard deviation (SD) in case of normal 
distribution. Data from different groups were 
compared using the Mann-Whitney U test and the 
Kruskal-Wallis test. Statistical significance was 
assumed at p < 0.05. 
Results 
Clinical course and functional results 
Two animals (11%) died in the treated group (A), 
one animal due to postoperative sepsis and another 
animal during anesthesia, respectively. No animals 
from the control groups C1 and C2 died. No other 
severe complications higher than grade II 
(Clavien-Dindo classification) were observed. The 
bladder capacity did not change in the treated group 
A but reduced significantly in the control group C1 
with suture of the lesion (p=0.01) (Fig. 2). 
Macroscopic examination 
7 days 
No signs of severe inflammation were found in 
the abdominal cavity during resurgery. 
Meso-adhesions to the HAM graft were detected in 
most treated cases. The multilayer amnion was clearly 
detectable as a shiny, reddish layer on the bladder 
wall. HAM appeared as a thick, edematous graft with 
inflammation running from the middle towards the 
transition zone of the bladder wall. Blister formation 
was seen in one case. Inflammation was less 
prominent in the control groups (C1 and C2). 
 
 
Figure 2. Bladder capacity pre- and postoperatively in the amnion treated 
group A and control group C1. The bladder capacity reduced significantly in the 
control group due to the scaring of the sutured lesion (* p˂0.05). 
 
21 days 
HAM was still well defined, albeit with reduced 
inflammation. The edema had almost disappeared 
and the amnion graft appeared as a reddish layer on 
the bladder wall (Fig. 3). Adhesions were still present 
in some cases. 
42 days 
HAM was still recognizable, but the colour had 
changed to a whitish-grey with signs of inflammation 
and blood vessels formation in the transition zone of 
the bladder wall (Fig. 3). 
Microscopic examination 
7 days 
The xenotransplanted HAM graft covered the 
bladder wall and maintained its architecture in the 
treated group. The lesions could be recognized as the 
regions without smooth muscle cells but with 
abundant connective tissue and signs of 
inflammation. Significant inflammation and increased 
blood vessels numbers were observed in the amnion 
and between the amnion and the adventitia of the 
bladder, which resulted in an enlarged amnion. 
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Infiltrated lymphocytes agglomerated mostly in the 
area bordering the HAM. No shrinkage of the 
transplanted grafts was seen in any of the specimens. 
Lower inflammation levels were found in the control 
groups C1 and C2 (Fig. 4). 
 
 
Figure 3. Macroscopic and histological evaluation (H&E staining) of inflammation and AM degradation over time (21 and 42 days after grafting). Reduction of 
inflammation over time. Decreased inflammatory cells (*) and increased vascularization (V) in the periamniotic transition zone were detected. No signs of AM 
degradation. Scale bar 200µm. 
 
Figure 4. Reduction of inflammation over time, semiquantative analyses of inflammatory cells: Treated (A): Amnion repair of bladder defect. Control/Lesion (C1): 
Closure of bladder defect with suture. Control/Amnion (C2): Amnion bladder onlay without defect. Semi-quantitative score: 0 = <5% cells/field; 1 = 5-25%; 2 = 
25-50%; 3 = >50%; 200x magnification. Data is expressed as median with range. *, significant reduction (p˂0.05). 
 
Figure 5. Measurement of amnion thickness over time (7, 21 and 42 days): Treated (A): Amnion repair of bladder defect. Control/Amnion (C2): Amnion bladder 
onlay without defect. Data is expressed as mean with SD, p˂0.05. 
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Figure 6. Immunohistological analysis of a reconstructed urinary bladder wall at timepoint 3 (42 days). A: Amnion group, reconstruction with AM graft; B: Control 
group, reconstruction with suture, AM; Amniotic membrane, Ur; Urothelium, BL; lumen of urinary bladder, X; region of lesion in the bladder wall. (A) H&E staining 
displaying mild inflammatory infiltration. α-Actin staining reveals frequently arranged smooth muscle bundles (arrows). Strong immunoreactivity underneath the 
urothelium layer is observed. The region of the lesion can be clearly recognized in the control group with muscle bundles, while there is a smooth muscle ingrowth 
in the treated group. 
 
21 days 
The amnion including its different layers was 
mostly still clearly recognizable. No signs of amnion 
degradation or necrosis were observed, but the 
amnion appeared less thick compared to time point 1 
(Fig. 5). Inflammation of the amnion was significantly 
diminished (p<0.05) (Fig. 3, Fig. 4 and Fig. 6). 
However, a moderate number of lymphocytes and a 
few eosinophils were detected in the transition zone 
between the graft and the surroundig tissue. New 
capillaries started to grow into the surrounding 
connective tissues and scattered smooth muscle cells 
appeared in the area of the lesion. In the control 
groups C1 and C2 signs of inflammations (presence of 
lymphocytes) had mostly disappeared and the 
differences were less obvious. More connective tissue 
with scattered smooth muscle cells was discerned 
(Fig. 3). 
42 days 
It has become more difficult to discriminate the 
region of the lesion in the treated group, where the 
amnion formed a thinner layer on the bladder wall 
with no signs of degradation (Figures 3 and 5). 
Inflammation was markedly reduced in the amnion 
and in the zone between the amnion and the bladder 
wall (p<0.05) (Figures 3 and 4). The number of large 
vessels in the amnion appeared to be reduced and 
periamniotic vascularization increased but these 
results were not significant. Connective tissue, 
bundles and thin muscle layers were abundantly 
found in all groups. Smooth muscle regeneration 
appeared faster in the treated group (Fig. 6), although 
the difference in the regeneration compared to the 
control group with suture of the lesion was not 
significant (p<0.05). 
Rejection 
No macroscopic signs of rejection were found in 
the kidney or spleen specimens. However, 4 out of 6 
animals in the treated group showed an affected 
kidney at time point 2. The changes were subtle with 
slightly enlarged tubuli and urinary space. The 
glomeruli appeared denser. No immune cells or other 
signs of transplant rejection were observed. At time 
point 3, only the kidneys of 2 of the 5 animals were 
still slightly affected, while no such alterations were 
detected in the controls without amnion had no such 
alterations. To exclude an obstruction or increased 
bladder pressure due to the HAM graft as the cause 
for these findings, we compared the results with 
another study, where we used amnion graft on colon 
(unpublished data). The same alterations were 
detected in the kidneys in this group. Taken together, 
a subtle, transient transplant glomerulitis is suggested 
in case of HAM graft in a rat. 
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Discussion 
The aim of our study was to assess the 
functional, inflammatory and allergenic 
characteristics of human amniotic membrane in a 
xenograft rat model.  
HAMs have been widely used for decades in 
ophthalmic surgery, mainly to cover defects after 
corneal ulcerations [15, 16]. Today, HAM grafts are 
considered the standard therapy to reconstruct the 
eye surface as shown in several randomized and 
controlled trials [17, 18]. The effectiveness of HAMs 
has been amply demonstrated in several clinical 
studies, for instance, as skin graft donor site dressing 
in burn patients or for the reconstruction of dental 
defects and oro-pharyngeal fistulas [19-22]. 
Furthermore, tissue-engineered HAMs have been 
used as matrix for cell seeding and expansion of 
epithelial progenitor cells in ophthalmology, 
orthopedics, healing of liver dysfunction, etc. [23, 24]. 
Currently there is a growing interest in 
extending the application possibilities of HAMs due 
to their wide availability, low costs and interesting 
properties. The technique of applying HAMs in 
reconstructive urology was introduced for the first 
time in 1955 although only a few groups applied AM 
to repair the urinary tract wall [25]. Reconstruction of 
urethrae with HAMs in a rabbit model showed a 
proper re-epithelialization, and even better results 
could be achieved with a denuded human amniotic 
scaffold inoculated with primary rabbit urethral 
epithelial cells [26, 27]. A Polish group described a 
technique to supplement long ureteral wall strictures 
(5.5 cm) by using folded HAM allografts and 
presented good, sustainable results after an average 
follow-up period of 25.2 months [28]. Brandt and 
coworkers successfully reconstructed a female urethra 
using autologous grafts prepared from HAMs [29]. 
Reconstruction of a complex vesico-vaginal fistula 
with a HAM interposition patch was shown in two 
case reports [30, 31]. Excellent integration of the 
implanted amnion graft within the host urinary tract 
wall and reduced fibrosis were reported after the 
reconstructive procedures. Adamowicz and 
coworkers designed a sandwich-structured 
biocomposite material from a frozen cell-seeded (bone 
marrow-derived mesenchymal stem cells) HAM and 
covered it on both sides with two-layered membranes 
prepared from electrospun poly-(L-lactide-co- 
ecaprolactone) (PLCL). The authors considered this 
reinforcement of the AM necessary because of its poor 
mechanical qualities. The new biomaterial (10x10 
mm) was used for bladder augmentation after 
hemicystectomy in 10 rats, which were sacrificed after 
3 months [32]. Immunohistohemical analysis revealed 
effective regeneration of the urothelial and smooth 
muscle cells and complete PLCL degradation. 
However, the authors reported a moderate 
inflammatory reaction after 3 months. 
In contrast, the results of our study confirm 
previous reports in which the elasticity and durability 
of multilayer HAMs were described and no signs of 
leakage and unchanged bladder capacity were 
observed after the reconstruction. A modified “simple 
cystometry” by infusion of flood by gravity at a 
pressure head of 20cm was used in our experiments, 
sensitivity comparable to standard multichannel 
cystometry [33]. The cystometric results were highly 
reproducible on repeated assessments, confirming the 
reliability of this procedure to assess the bladder 
capacity in the rat model. The differences in bladder 
volume change were only about <15% of the total 
volume, due to a small defect. More obvious 
reduction of bladder capacity is known from patients 
with partial bladder resection with the need for 
augmentation surgery. Future studies with larger 
grafts are planned. 
The inflammatory reaction had almost 
disappeared already after 6 weeks. The mechanical 
behavior of the urinary bladder is dependent on the 
properties of the extracellular matrix and smooth 
muscle cells. The extracellular matrix (ECM) of HAMs 
is composed of collagen (type I, III, IV, V and VI), 
fibronectin, nidogen, laminin, proteoglycans and 
hyaluronan in a proportion that is similar to the 
basement membrane of urinary tracts [34]. With a 
diameter of about 150 - 200 nm amniotic membrane is 
one of the thickest membranes of the human body and 
its stroma provides elasticity and mechanical strain. 
Large grafts need sufficient nutrition of the cells and 
removal of waste products to eliminate/reduce the 
risk of fibrosis and shrinkage. Having a diffusion 
distance from the supplying blood vessel of ~150-200 
µm, HAMs efficiently conduct sufficient oxygenation 
of cells by diffusion [35]. No signs of graft shrinkage 
or necrosis were found during the 6-wk follow-up 
period.  
The limitations of our study were the small size 
of the grafts (10x10mm), missing detailed data on 
immunological process of regeneration and the short 
follow-up period. Regeneration in large constructs or 
even neo-bladder needs further evaluation. Multiple 
soluble active growth factors have been identified 
within cryopreserved HAMs [36]. This naturally 
derived composition of incorporated growth factors is 
predisposed to support fetal healing - rapidly and 
without an inflammatory response - resulting in a 
complete restitution of normal tissue function [37]. 
HAMs secrete the glycoprotein lumican and growth 
factors like epidermal growth factor (EGF), a 
hepatocyte growth factor (HGF) and keratinocyte 
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growth factor (KGF), which stimulate epithelial cell 
growth [36]. Wound healing is a highly complex 
process of inflammation, regeneration of tissue, 
angiogenesis, scarring and reepithelialization. 
Amnion was previously described to reduce the scar 
tissue building by the inhibition of fibroblasts. There 
is no scarring after the child injuries in the amniotic 
sac. Kim and Tseng transplanted HAM for surface 
reconstruction of cornea in vitro and in animal studies 
[15]. They detected reduced fibroblast building by 
suppression of Transforming growth factor-ß (TGF-ß). 
Further studies confirmed that amniotic stroma 
includes factors which inhibit the proliferation of 
myofibroblasts [38]. The results of the presented study 
support the hypothesis of faster tissue regeneration by 
inhibition of scar building. However, a detailed 
immunohistological investigation of regeneration 
process in larger grafts would be a part of the future 
work to be done. Although we expected a faster 
regeneration of smooth muscle in the amnion group 
due to the presence of growth factors, our results were 
not significant in this respect and it was not possible 
to compare the regeneration in a standardized way 
due to the small size of the grafts used and an overlap 
with the normal bladder wall. 
The overall low complication rate was 
comparable to previous reports [26-32]. One animal in 
the treated group (5.6%) died due to sepsis. All 
animals in the amnion group presented a transient 
local inflammation and the amnion group included 
several cases of local abdominal adhesions, but no 
signs of peritonitis. Akle and Adolfini detected no 
signs of acute rejection after allogen subcutaneously 
implanted HAMs [39]. Fas ligand positive cells, 
suppression of TGF-ß are other examples for 
immunological privilege of the amniotic membrane. 
The marked edema in the first week and high 
inflammation score in the amnion graft group may 
reflect the local immunological rejection in the 
presented study. However, this reaction is transient 
and no differences between the groups were found in 
follow up. A similar transient increase in 
inflammatory cells was reported by Kesting et al., 
who used cryopreserved HAMs for soft tissue repair 
in rats [40]. Additionally, most animals of the amnion 
group presented a subtle acellular transplant 
glomerulitis. These changes can be classified as 
borderline mild acute rejection according to the Banff 
classification [41]. However, due to the relatively 
short follow-up period, it was not possible to 
determine whether chronic glomerulitis with 
interstitial fibrosis and tubular atrophy would 
develop. Still, 2 of 5 animals were slightly affected in 
the amnion group. We suggest that the glomerulitis 
observed during our experiments was due to the 
xenolog model and that glomerulitis would normally 
not develop in an allogen human setting. However, 
further studies on immunological process are needed 
to confirm this assumption. 
We suggest that HAMs are appropriate for the 
reconstruction of small defects (fistula grafting, 
urethro- and ureteroplasty), but not of the whole 
organ, which requires healthy tissue ingrowth. 
Experiments with larger scaffolds need to be 
conducted to further explore the clinical potential of 
HAMs. Following the IDEAL-D recommendations, 
further evaluation of possible indications in clinical 
studies is needed after successful stage 0 experimental 
results. 
Conclusions 
Preclinical xenotransplantation model supports 
the application of HAMs for reconstruction of urinary 
tract. Successful closure of defined bladder wall 
defects could be achieved by using multilayered 
HAMs. The inflammation and rejection were subtle 
and transient and smooth muscle ingrowth appeared 
to be enhanced. These findings need further support 
by research in larger animals and in human allogen 
settings to explore immunological HAM impact and 
possible further applications of HAMs in 
reconstructive surgery. 
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